tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Perspective Therapeutics price target lowered to $11 from $12 at B. Riley
PremiumThe FlyPerspective Therapeutics price target lowered to $11 from $12 at B. Riley
19d ago
Tango Therapeutics price target raised to $14 from $8 at B. Riley
Premium
The Fly
Tango Therapeutics price target raised to $14 from $8 at B. Riley
19d ago
Tango Therapeutics initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Tango Therapeutics initiated with a Peer Perform at Wolfe Research
20d ago
Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study
PremiumCompany AnnouncementsRevolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study
1M ago
Tango Therapeutics’ Promising Update on TNG260 Clinical Study
Premium
Company Announcements
Tango Therapeutics’ Promising Update on TNG260 Clinical Study
1M ago
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors
Premium
Company Announcements
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors
1M ago
Tango Therapeutics Announces Preliminary Financial Results
PremiumCompany AnnouncementsTango Therapeutics Announces Preliminary Financial Results
2M ago
Tango Therapeutics prices 21M shares at $8.66 in underwritten offering
Premium
The Fly
Tango Therapeutics prices 21M shares at $8.66 in underwritten offering
2M ago
Tango Therapeutics announces positive data from Phase 1/2 study of vopimetostat
Premium
The Fly
Tango Therapeutics announces positive data from Phase 1/2 study of vopimetostat
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100